05/16/2025
2:35 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
2:36 PM | Lexeo Therapeutics (Subject)
See Tai Sandi (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
2:41 PM | Lexeo Therapeutics (Subject)
Robertson Jenny (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
2:51 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
8:58 AM | D1 Capital Partners L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
11:00 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
5:55 AM | Lexeo Therapeutics (Subject)
MIZUHO FINANCIAL GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
8:00 AM | Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
6:02 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:03 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2025
4:44 PM | Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LXEO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/09/2025
4:46 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
4:48 PM | Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
5:06 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
6:58 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:17 PM | Lexeo Therapeutics (Filer)
| Form S-8 POS | |
03/24/2025
6:52 AM | Lexeo Therapeutics (Filer)
| Form 424B5 | |
03/24/2025
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
6:03 AM | Lexeo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/24/2025
6:04 AM | Lexeo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025
4:08 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:09 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:09 PM | Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:10 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:06 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
11:03 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
10:55 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
8:00 AM | Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
9:24 AM | Lexeo Therapeutics (Subject)
MIZUHO FINANCIAL GROUP INC (Filed by)
| Form SCHEDULE 13G | |
02/12/2025
8:35 AM | Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025
3:55 PM | Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:35 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:55 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:55 PM | Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:55 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:55 PM | Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:55 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
1:59 PM | Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2024
11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
12/19/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
7:19 AM | Lexeo Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Trump + Musk = AI’s turning point (Ad) Trump may not code… but he knows how to pick winners.
And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech.
Elon Musk has already poured $51 million into it. Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. |
12/12/2024
4:00 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:18 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
11/26/2024
4:00 PM | CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:49 PM | Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/14/2024
11:32 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:23 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:31 PM | Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:33 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:34 PM | Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
6:31 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:32 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
6:33 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:35 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
5:15 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:17 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
12:45 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:30 PM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:32 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
09/11/2024
4:17 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:39 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
5:34 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:11 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
08/09/2024
8:43 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
08/05/2024
11:54 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
07/15/2024
6:55 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:59 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
07/12/2024
3:55 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
5:20 PM | Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:26 PM | Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
6:04 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/28/2024
6:33 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
6:36 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/27/2024
4:01 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:01 PM | CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:02 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:04 PM | Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:05 PM | COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
8:04 AM | Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy LXEO Stock Free LXEO Stock Alerts